MTND5P9

Across TCGA pan-cancer cohorts, MTND5P9 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MTND5P9 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher MTND5P9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTND5P9 expression acts as an unfavorable survival marker, although some lineages such as STAD and ESCA show a favorable association.

UVM, STAD, and BRCA are the cancer types where MTND5P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.292	0.864	<.001	108	view →
STAD	OS	Tertile	All	0.697	0.388	.018	60	view →
BRCA	DFS	Tertile	All	0.169	0.537	<.001	60	view →
BLCA	DFS	Tertile	IV	0.131	0.479	.009	27	view →
ESCA	DFS	Tertile	III,IV	0.646	0.269	.033	12	view →
PCPG	OS	Tertile	All	0.888	1.000	.002	9	view →
CESC	OS	Tertile	All	0.584	0.876	.047	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MTND5P9–UVM (OS)

Open the UVM breakdown →